Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Novo Nordisk’s stock dives as new weight loss drug disappoints in a late-stage trial, which gave a boost to Eli Lilly shares.

Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new ...

The Ozempic maker's stock tanked after its highly anticipated CagriSema drug trial showed an average of 22.7% weight loss, ...

Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...

Research reveals a link between Ozempic and Wegovy, popular weight loss and diabetes medications, and an increased risk of ...

Ozempic before and after photos show weight loss. Women share what it's like to lose weight with Ozempic and Wegovy, the side ...

Researchers have achieved impressive results in animal studies with a new weight-loss drug that has no GLP-1-style side ...

A new analysis estimates that losing as little as 5% weight can lead to substantial savings in health care costs elsewhere.

Independence Blue Cross joins other insurance companies in restricting coverage of Wegovy and Ozempic to Type 2 diabetes and ...

Ozempic, but the negative effects of the now Holywood famous drug can heavily outweigh the positives in the long run. Really, ...